Sariaslan Amir, Leucht Stefan, Zetterqvist Johan, Lichtenstein Paul, Fazel Seena
Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK.
Social and Public Policy Unit, Faculty of Social Sciences, University of Helsinki, Helsinki, Finland.
Psychol Med. 2021 Mar 11;52(16):1-9. doi: 10.1017/S0033291721000556.
Individuals diagnosed with psychiatric disorders who are prescribed antipsychotics have lower rates of violence and crime but the differential effects of specific antipsychotics are not known. We investigated associations between 10 specific antipsychotic medications and subsequent risks for a range of criminal outcomes.
We identified 74 925 individuals who were ever prescribed antipsychotics between 2006 and 2013 using nationwide Swedish registries. We tested for five specific first-generation antipsychotics (levomepromazine, perphenazine, haloperidol, flupentixol, and zuclopenthixol) and five second-generation antipsychotics (clozapine, olanzapine, quetiapine, risperidone, and aripiprazole). The outcomes included violent, drug-related, and any criminal arrests and convictions. We conducted within-individual analyses using fixed-effects Poisson regression models that compared rates of outcomes between periods when each individual was either on or off medication to account for time-stable unmeasured confounders. All models were adjusted for age and concurrent mood stabilizer medications.
The relative risks of all crime outcomes were substantially reduced [range of adjusted rate ratios (aRRs): 0.50-0.67] during periods when the patients were prescribed antipsychotics v. periods when they were not. We found that clozapine (aRRs: 0.28-0.44), olanzapine (aRRs: 0.46-0.72), and risperidone (aRRs: 0.53-0.64) were associated with lower arrest and conviction risks than other antipsychotics, including quetiapine (aRRs: 0.68-0.84) and haloperidol (aRRs: 0.67-0.77). Long-acting injectables as a combined medication class were associated with lower risks of the outcomes but only risperidone was associated with lower risks of all six outcomes (aRRs: 0.33-0.69).
There is heterogeneity in the associations between specific antipsychotics and subsequent arrests and convictions for any drug-related and violent crimes.
被诊断患有精神疾病并开具抗精神病药物处方的个体暴力和犯罪率较低,但特定抗精神病药物的差异影响尚不清楚。我们调查了10种特定抗精神病药物与一系列犯罪后果后续风险之间的关联。
我们利用瑞典全国性登记系统,确定了2006年至2013年间曾开具过抗精神病药物处方的74925名个体。我们测试了5种特定的第一代抗精神病药物(左美丙嗪、奋乃静、氟哌啶醇、氟哌噻吨和氯普噻吨)和5种第二代抗精神病药物(氯氮平、奥氮平、喹硫平、利培酮和阿立哌唑)。结果包括暴力、与毒品相关以及任何刑事逮捕和定罪。我们使用固定效应泊松回归模型进行个体内分析,比较每个个体服药期和停药期的结果发生率,以考虑时间稳定的未测量混杂因素。所有模型均对年龄和同时使用的心境稳定剂进行了调整。
与未开具抗精神病药物处方的时期相比,患者开具抗精神病药物处方期间所有犯罪结果的相对风险大幅降低[调整率比(aRRs)范围:0.50 - 0.67]。我们发现,与其他抗精神病药物相比,氯氮平(aRRs:0.28 - 0.44)、奥氮平(aRRs:0.46 - 0.72)和利培酮(aRRs:0.53 - 0.64)与较低的逮捕和定罪风险相关,包括喹硫平(aRRs:0.68 - 0.84)和氟哌啶醇(aRRs:0.67 - 0.77)。作为联合药物类别的长效注射剂与较低的结果风险相关,但只有利培酮与所有六种结果的较低风险相关(aRRs:0.33 - 0.69)。
特定抗精神病药物与任何与毒品相关和暴力犯罪的后续逮捕和定罪之间的关联存在异质性。